Skip Nav Destination

First Edition

Research Article September 27 2024

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

Ashraf Z Badros,Laahn Foster,Larry D. Anderson, Jr.,Chakra P. Chaulagain,Erin M Pettijohn,Andrew J Cowan,Caitlin L. Costello,Sarah Larson,Douglas W Sborov,Kenneth H Shain,Rebecca Silbermann,Nina Shah,Alfred Chung,Maria Krevvata,Huiling Pei,Sharmila Patel,Vipin Khare,Annelore Cortoos,Robin Carson,Thomas Lin,Peter M Voorhees

View article

Supplementary data

Research Article September 24 2024

A bulge uridine in the HIF2a IRE allows IRP1 but not IRP2 to selectively regulate HIF2a expression and ensuing EPO levels

De-Liang Zhang,Hayden Ollivierre,Chen-Feng Qi,Tracey A. Rouault

View article

Supplementary data

Review Article September 24 2024

The present and future for CAR-T cell therapy in adult B-cell ALL

Claire Roddie,Alexandros Rampotas

View article

Review Article September 24 2024

How I Treat patients with AML using azacitidine and venetoclax

Andrew H. Wei,Sun Loo,Naval G Daver

View article

Supplementary data

Review Article September 18 2024

Management of iron overload: lessons from transfusion-dependent hemoglobinopathies

Thomas D Coates

View article

Supplementary data

Review Article September 6 2024

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old

Roland B. Walter,Victoria Potter,Charles Craddock

View article

Review Article September 5 2024

TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?

David A Sallman,Maximilian Stahl

View article

Review Article September 5 2024

Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia.

Talha Badar,Selina M. Luger,Mark R Litzow

View article

Review Article July 26 2024

Treatment of Relapsed/Refractory MCL

Elisabeth Silkenstedt,Martin Dreyling

View article

Review Article July 24 2024

How I (Diagnose and) Treat Myeloid / Lymphoid Neoplasms with Tyrosine Kinase Gene Fusions

Andreas Reiter,Georgia Metzgeroth,Nicholas C.P. Cross

View article

Review Article July 8 2024

How I Treat: Differentiation Therapy in Acute Myeloid Leukemia

Ghayas C. Issa,Eytan M. Stein,Courtney D. D DiNardo

View article

Review Article June 28 2024

How I treat iron overload in adult myelodysplastic syndrome

Heather A Leitch,Rena J. Buckstein

View article

Supplementary data

Review Article June 7 2024

How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction

Mary Frances McMullin,Claire N. Harrison

View article

Review Article June 7 2024

How I manage major hemorrhage

Jeannie L Callum,Ronald B George,Keyvan Karkouti

View article

Review Article May 14 2024

How I manage pregnant patients who are alloimmunized to RBC antigens

Helen Frances Savoia,Anna Parakh,Stefan Charles Kane

View article

Review Article May 10 2024

How I Treat Challenging Transfusion Cases in Sickle Cell Disease

Stella T. Chou,Jeanne E Hendrickson

View article

Review Article May 10 2024

How I manage iron overload in the hemopoietic cell transplantation setting

Emanuele Angelucci

View article

Review Article March 29 2024

Unraveling MCL biology to understand resistance and identify vulnerabilities

clémentine Sarkozy,Benoit Tessoulin,David Chiron

View article

Review Article March 18 2024

Frontline Treatment of Mantle Cell Lymphoma

Christine E Ryan,Philippe Armand,Ann S LaCasce

View article

Page 3 of 3

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma

High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia

Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Doubling down on GPRC5D in multiple myeloma

Advertisement intended for health care professionals

First Edition

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

A bulge uridine in the HIF2a IRE allows IRP1 but not IRP2 to selectively regulate HIF2a expression and ensuing EPO levels

The present and future for CAR-T cell therapy in adult B-cell ALL

How I Treat patients with AML using azacitidine and venetoclax

Management of iron overload: lessons from transfusion-dependent hemoglobinopathies

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old

TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?

Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia.

Treatment of Relapsed/Refractory MCL

How I (Diagnose and) Treat Myeloid / Lymphoid Neoplasms with Tyrosine Kinase Gene Fusions

How I Treat: Differentiation Therapy in Acute Myeloid Leukemia

How I treat iron overload in adult myelodysplastic syndrome

How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction

How I manage major hemorrhage

How I manage pregnant patients who are alloimmunized to RBC antigens

How I Treat Challenging Transfusion Cases in Sickle Cell Disease

How I manage iron overload in the hemopoietic cell transplantation setting

Unraveling MCL biology to understand resistance and identify vulnerabilities

Frontline Treatment of Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

First Edition

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only